ACE2 News and Research

RSS
A rapid and affordable in vitro model to test SARS-CoV-2 susceptibility in animal species

A rapid and affordable in vitro model to test SARS-CoV-2 susceptibility in animal species

Protein OCLN found to play crucial role in SARS-CoV-2 cell-to-cell transmission

Protein OCLN found to play crucial role in SARS-CoV-2 cell-to-cell transmission

Unravelling the factors influencing host tropism of SARS-CoV-2-related bat coronaviruses

Unravelling the factors influencing host tropism of SARS-CoV-2-related bat coronaviruses

Is there an association between COVID-19 and the risk of developing an autoimmune disease?

Is there an association between COVID-19 and the risk of developing an autoimmune disease?

Study develops a novel intranasal influenza virus-vectored vaccine for SARS-CoV-2

Study develops a novel intranasal influenza virus-vectored vaccine for SARS-CoV-2

The virological characteristics of XBB.1.16

The virological characteristics of XBB.1.16

VUMC-led trial demonstrates the inefficacy of two investigational drugs for treating severe COVID-19

VUMC-led trial demonstrates the inefficacy of two investigational drugs for treating severe COVID-19

Scientists isolate two antibodies that neutralize all current SARS-CoV-2 variants of concern

Scientists isolate two antibodies that neutralize all current SARS-CoV-2 variants of concern

Study finds human surfactant protein A can inhibit SARS-CoV-2 infectivity

Study finds human surfactant protein A can inhibit SARS-CoV-2 infectivity

Study highlights the potential long-term neurological effects post-COVID-19

Study highlights the potential long-term neurological effects post-COVID-19

Study reveals SARS-CoV-2 on hands and frequently-touched surfaces as key predictors of household transmission

Study reveals SARS-CoV-2 on hands and frequently-touched surfaces as key predictors of household transmission

Study explores the species-specific use of ACE2 receptors by human and animal coronaviruses

Study explores the species-specific use of ACE2 receptors by human and animal coronaviruses

The association between neutralizing antibody response breadth and long COVID symptoms

The association between neutralizing antibody response breadth and long COVID symptoms

Drug used to treat liver disease may decrease SARS-CoV-2 infections and reduce COVID-19 severity

Drug used to treat liver disease may decrease SARS-CoV-2 infections and reduce COVID-19 severity

Pre-existing immunity shapes mucosal SARS-CoV-2-specific antibody responses

Pre-existing immunity shapes mucosal SARS-CoV-2-specific antibody responses

Oral antiviral CD04872SC shows promise in neutralizing COVID-19 variants, offering hope for broad-spectrum treatment

Oral antiviral CD04872SC shows promise in neutralizing COVID-19 variants, offering hope for broad-spectrum treatment

Study identifies ultra-broad SARS-CoV-2 neutralizing antibodies that target various spike epitopes

Study identifies ultra-broad SARS-CoV-2 neutralizing antibodies that target various spike epitopes

COVID-19 activates endogenous retroviruses within our genome

COVID-19 activates endogenous retroviruses within our genome

New study suggests broad neutralizing antibody could provide three years of COVID protection

New study suggests broad neutralizing antibody could provide three years of COVID protection

Epigenome reprogramming after SARS-CoV-2 infection

Epigenome reprogramming after SARS-CoV-2 infection